Overview

A Phase 2 Study of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Diet and Exercise

Status:
COMPLETED

Trial end date:
2023-01-17

Target enrollment:

Participant gender:

Summary

The goal of this clinical trial is to evaluate the efficacy and safety of berberine ursodeoxycholate (HTD1801) compared to placebo in patients with type 2 diabetes inadequately controlled with diet and exercise alone.

Phase:

PHASE2

Details

Lead Sponsor:

HighTide Biopharma Pty Ltd

Collaborator:

Shenzhen HighTide Biopharmaceutical Ltd.